Found 36 matching trials
Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination PHASE3 The purpose/aim of this study is to assess the safety and antibody response...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Understanding the Immune Response to Two Different Meningitis Vaccines PHASE4 The bacterium (germ) Neisseria meningitidis causes meningitis and blood poi...
Show More Location
Oxford Vaccine Group
Treatments Being Tested
MenACWY-CRM conjugate vaccine (Menveo, Novartis) MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis) MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis) 1/5th dose MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis) Polysaccharide (subcutaneously)-conjugate Learn More & Join Trial
MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age PHASE3 The aim of this study is to determine the immunologic noninferiority of Men...
Show More Location
Alabama Clinical Therapeutics, LLC, Birmington Pediatric Assocaites
Learn More & Join Trial
Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age PHASE3 Safety and immunogenicity of meningococcal ACWY conjugate versus polysaccha...
Show More Location
FUNCEI, French 3085
Learn More & Join Trial
Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children PHASE3 To evaluate the safety and immune response of Novartis MenACWY conjugate va...
Show More Location
Children's Investigational Reserach Program
Learn More & Join Trial
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine PHASE3 This study compares the safety and immunogenicity profile of combined hepat...
Show More Location
03, Novartis Investigational Site
Learn More & Join Trial
Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects 2 Years of Age and Older N/A A multicenter, single arm, postmarketing surveillance study. This study is ...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan PHASE3 This study will evaluate the immunogenicity and safety of a single injectio...
Show More Location
Mackay Memorial Hospital,
Learn More & Join Trial
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults PHASE3 This study will evaluate the lot to lot consistency, safety and immune resp...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults PHASE3 This study will evaluate the safety and immune response of Novartis Meningo...
Show More Location
Buenos Aires, Argentina
Learn More & Join Trial